Eterna Therapeutics
ERNA
9 hedge funds and large institutions have $1.69M invested in Eterna Therapeutics in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
13% more funds holding
Funds holding: 8 → 9 (+1)
33% less capital invested
Capital invested by funds: $2.54M → $1.69M (-$850K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$42.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NSIM
North Star Investment Management
Chicago,
Illinois
|
-$42.6K |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NSIM
1
North Star Investment Management
Chicago,
Illinois
| $691K | -$42.6K | -1 | -5% |
|
|
BA
2
Bard Associates
Chicago,
Illinois
| $596K | – | – | – |
|
3
Renaissance Technologies
New York
| $131K | – | – | – |
|
4
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $66K | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| $46K | – | – | – |
|
|
CA
6
Callahan Advisors
Houston,
Texas
| $41K | – | – | – |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $41K | – | – | – |
|
|
8
Citadel Advisors
Miami,
Florida
| $38K | +$42.6K | +1 | New |
|
9
Vanguard Group
Malvern,
Pennsylvania
| $36K | – | – | – |
|
10
BlackRock
New York
| $7K | – | – | – |
|
|
11
Victory Capital Management
San Antonio,
Texas
| – | -$1K | – | – |
|
ERNA Hedge Fund Activity: Q4 2019 in Review
9 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2019, worth a combined $1.69M — down 33% from $2.54M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ERNA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $42.6K. The largest seller was North Star Investment Management, cutting an estimated $42.6K.
- 9 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2019, up from 8 in Q3 2019.
- Funds reported $1.69M of Eterna Therapeutics stock for Q4 2019, down 33% quarter-over-quarter.
- 1 fund opened new Eterna Therapeutics positions in Q4 2019 and 0 closed out, a net change of +1 holder.
- The largest Eterna Therapeutics buyer in Q4 2019 was Citadel Advisors, an estimated $42.6K added.
- The largest Eterna Therapeutics seller in Q4 2019 was North Star Investment Management, an estimated $42.6K sold.
Based on aggregated 13F filings for Q4 2019.